ONCOTELIC TO PARTICIPATE AT THE ASCO 2024 MEETING

AGOURA HILLS, Calif., May 20, 2024 -- Oncotelic Therapeutics, Inc announced today its Chief Clinical Officer- Dr. Anthony Maida will be participating at the ASCO 2024 meeting. Abstract: e16318....

Related Keywords

Anthony Maida ,Mateon Therapeutics Inc ,Pointr Data Inc ,Globenewswire Inc ,Oxigene Inc ,Company Annual Report On Form ,Oncotelic Therapeutics Inc ,Chief Clinical ,New York ,Diffuse Intrinsic Pontine Glioma ,Acute Myeloid Leukemia ,Parkinson Disease ,Annual Report ,Cautionary Note ,Private Securities Litigation Reform Act ,